Cost minimisation of RSV prevention with palivizumab [10]

Archives of Disease in Childhood

Volumn 91, Issue 8, 2006, Pages 717-

  Wills, S ^a   Simpson, J H ^a   Coutts, J ^a  

^a QUEEN MOTHER S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB;

CONGENITAL HEART DISEASE; CONGENITAL LUNG DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST MINIMIZATION ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; INFANT; INFECTION PREVENTION; LETTER; NEWBORN; PATIENT REFERRAL; PATIENT SELECTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CHILD; COST SAVINGS; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 33746917150     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.093484     Document Type: Letter

References (0)